Cullinan Therapeutics, Inc. · NASDAQ:CGEM

BVF PARTNERS L P/IL reported a 9.99% stake in Cullinan Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

BVF PARTNERS L P/IL reported a 9.99% stake in Cullinan Therapeutics, Inc., 6,161,469 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
6,161,469
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P5.80%3,551,482
BVF I GP LLC5.80%3,551,482
BIOTECHNOLOGY VALUE FUND II LP3.70%2,272,849
BVF II GP LLC3.70%2,272,849
Biotechnology Value Trading Fund OS LP0.40%224,641
BVF Partners OS Ltd.0.40%224,641
BVF GP HOLDINGS LLC9.40%5,824,331
BVF PARTNERS L P/IL9.99%6,161,469
BVF INC/IL9.99%6,161,469
LAMPERT MARK N9.99%6,161,469

Source

View original at SEC

Related